Researchers discover a blood biomarker which could predict severe cognitive decline in patients with Parkinson's disease.
Increased ceramide levels in the brain may be a unique feature of all types of Lewy body dementias, including LBD associated with Parkinson's disease.
Researchers report the accumulation of glycosphingolipids in the substantia nigra appears to be elevated in Parkinson's disease patients. The finding could be used as a biomarker for helping diagnose Parkinson's before symptoms of the disease set in.
According to a new study, a protein called Tet3FL removes methyl groups from specific genes, keeping them active.